We are live on
!
Find out more
BC
Brinker Capital Portfolio holdings
AUM
$3.13B
1-Year Est. Return
9.04%
This Fund
S&P 500
This Quarter
Est. Return
+4.2%
1 Year Est. Return
+9.04%
3 Year Est. Return
+36.1%
5 Year Est. Return
+56.65%
10 Year Est. Return
–
AUM
$2.74B
AUM Growth
+$102M
(+3.9%)
Cap. Flow
+$9.17M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
24.29%
Holding
976
New
56
Increased
374
Reduced
499
Closed
44
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$6.29M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.41M |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$3.69M |
| 4 |
AbbVie
ABBV
|
+$3.47M |
| 5 |
Danaher
DHR
|
+$3.37M |
Top Sells
| 1 |
Ulta Beauty
ULTA
|
+$3.67M |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.24M |
| 3 |
Accenture
ACN
|
+$3.2M |
| 4 |
Mastercard
MA
|
+$3.17M |
| 5 |
Baxter International
BAX
|
+$2.4M |
Sector Composition
| 1 | Technology | 11.13% |
| 2 | Healthcare | 10.14% |
| 3 | Financials | 9.38% |
| 4 | Industrials | 8.01% |
| 5 | Consumer Discretionary | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Evergy
EVRG
$20B
| $1.55M | 0.06% |
25,725
+870
| +4% | +$50.9K |
|
|
PRAH
352
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.54M | 0.06% |
15,558
+31
| +0.2% | +$2.96K |
|
353
Yum China
YUMC
$15.2B
| $1.54M | 0.06% |
33,302
+1,878
| +6% | +$81.5K |
|
354
UBS Group
UBS
$175B
| $1.52M | 0.06% |
128,192
-20,477
| -14% | -$251K |
|
355
Churchill Downs
CHDN
$6.01B
| $1.51M | 0.06% |
26,322
-356
| -1% | -$17.9K |
|
356
Live Nation Entertainment
LYV
$41.9B
| $1.5M | 0.05% |
22,721
-175
| -0.8% | -$11.2K |
|
357
McKesson
MCK
$98.5B
| $1.49M | 0.05% |
11,109
+2,437
| +28% | +$304K |
|
358
James River Group Holdings
JRVR
$210M
| $1.49M | 0.05% |
31,781
+693
| +2% | +$30.2K |
|
359
Goldman Sachs
GS
$323B
| $1.49M | 0.05% |
7,279
-3,164
| -30% | -$626K |
|
360
First Citizens BancShares
FCNCA
$25B
| $1.49M | 0.05% |
3,297
-40
| -1% | -$17.5K |
|
361
Aptiv
APTV
$12.5B
| $1.48M | 0.05% |
18,277
-1,205
| -6% | -$95.4K |
|
|
EXAS
362
DELISTED
Exact Sciences
EXAS
| $1.48M | 0.05% |
12,506
-187
| -1% | -$18.8K |
|
363
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $1.48M | 0.05% |
16,556
+11,448
| +224% | +$1.01M |
|
|
GAP
364
The Gap Inc
GAP
$7.38B
| $1.47M | 0.05% |
+81,498
| New | +$1.83M |
|
365
ICU Medical
ICUI
$4.05B
| $1.46M | 0.05% |
5,807
+39
| +0.7% | +$9.04K |
|
366
Carter's
CRI
$1.46B
| $1.44M | 0.05% |
14,717
-785
| -5% | -$76.4K |
|
|
PPLI
367
People Inc
PPLI
$3.39B
| $1.44M | 0.05% |
36,924
-526
| -1% | -$21K |
|
368
Exelixis
EXEL
$14B
| $1.43M | 0.05% |
66,886
+19,679
| +42% | +$412K |
|
369
Power Integrations
POWI
$3.89B
| $1.43M | 0.05% |
35,614
+224
| +0.6% | +$8.19K |
|
370
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.56B
| $1.42M | 0.05% |
30,965
+15,407
| +99% | +$697K |
|
|
CDK
371
DELISTED
CDK Global, Inc.
CDK
| $1.4M | 0.05% |
28,232
-61
| -0.2% | -$3.27K |
|
372
iShares MSCI KLD 400 Social ETF
DSI
$5.32B
| $1.39M | 0.05% |
25,464
-282
| -1% | -$15.2K |
|
373
Hanover Insurance
THG
$7.24B
| $1.39M | 0.05% |
10,852
-35
| -0.3% | -$4.25K |
|
374
Silicon Motion
SIMO
$9.24B
| $1.39M | 0.05% |
31,202
-486
| -2% | -$19.5K |
|
375
Gilead Sciences
GILD
$169B
| $1.38M | 0.05% |
20,408
-1,839
| -8% | -$121K |
|
Similar funds
SCRM
FIM
GFPC
IC
I
MC
FTI
AWM
Brinker Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Brinker Capital held 976 positions worth $2.74B, up 3.9% from $2.64B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Brinker Capital's Q2 2019 filing shows 56 new, 374 increased, 499 reduced and 44 closed positions. Its largest new stake was IAA, Inc. Common Stock: 64,810 shares worth $2.51M. The largest sale was Ulta Beauty, an estimated $3.67M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Brinker Capital's largest Q2 2019 buy was IAA, Inc. Common Stock: 64,810 shares worth $2.51M.
- Brinker Capital added most to iShares Core S&P 500 ETF in Q2 2019, an estimated $6.29M increase.
- Brinker Capital's biggest Q2 2019 reduction was Ulta Beauty, cutting an estimated $3.67M.
- Brinker Capital fully exited Baxter International in Q2 2019, selling an estimated $2.4M.
- Brinker Capital's ten largest holdings make up 24% of its $2.74B portfolio in Q2 2019.
- Brinker Capital opened 56 new positions and closed 44 in Q2 2019.
- Brinker Capital's portfolio value rose 3.9% quarter-over-quarter to $2.74B.
Based on Brinker Capital's 13F filing for Q2 2019, filed 12 Aug 2019.